Why Did Stan Druckenmiller Sell Broadcom Stock?
In Q3, legendary macro investor Stan Druckenmiller sold his entire…
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 12/31/2025 | Q4 | $10M | -- | -- | -- | -- |
| 11/05/2025 | Q3 | $11.1M | $9.4M | -$0.19 | -- | -- |
| 08/12/2025 | Q2 | $11.2M | $9.4M | -$0.39 | -- | -- |
| 05/15/2025 | Q1 | -- | $8.9M | -$0.44 | -- | -- |
| 12/31/2024 | Q4 | $12.5M | $9.6M | -$0.84 | -- | -- |
| 11/05/2024 | Q3 | $11.8M | $8.4M | -$0.95 | -- | -- |
| 08/16/2024 | Q2 | $9M | $9.3M | -$9.94 | -- | -- |
| 05/20/2024 | Q1 | $7M | $7.5M | -$40.04 | -- | -- |
| 12/31/2023 | Q4 | $6.1M | $7.7M | -$104.66 | -- | -- |
| 11/13/2023 | Q3 | $6M | $6M | -$50.72 | -- | -- |
| 06/30/2023 | Q2 | -- | $5.6M | -$71.18 | -- | -- |
| 03/31/2023 | Q1 | -- | $4.9M | -$154.52 | -- | -- |
| 12/31/2022 | Q4 | -- | $3.9M | -$2,082.06 | -- | -- |
| 09/30/2022 | Q3 | -- | $132.8K | -$154.30 | -- | -- |
| 06/30/2022 | Q2 | -- | $150.3K | -$68.00 | -- | -- |
| 03/31/2022 | Q1 | -- | $122.6K | -$468.90 | -- | -- |
| 12/31/2021 | Q4 | -- | $85.1K | $102,980.00 | -- | -- |
| 09/30/2021 | Q3 | -- | $50.4K | -$3,176.00 | -- | -- |
| 06/30/2021 | Q2 | -- | $52.9K | -$2,408.00 | -- | -- |
| 03/31/2021 | Q1 | -- | $40.1K | -$5,640.00 | -- | -- |
| 12/31/2020 | Q4 | -- | $28K | -$1,252.00 | -- | -- |
| 09/30/2020 | Q3 | -- | $17.2K | -$996.00 | -- | -- |
| 06/30/2020 | Q2 | -- | $15.1K | -$2,372.00 | -- | -- |
| 03/31/2020 | Q1 | -- | $11.1K | -$1,040.00 | -- | -- |
| 12/31/2019 | Q4 | -- | $10.6K | -$4,480.00 | -- | -- |
| 09/30/2019 | Q3 | -- | $7.3K | -$16,960.00 | -- | -- |
| 06/30/2019 | Q2 | -- | $3K | -$10,480.00 | -- | -- |
| 03/31/2019 | Q1 | -- | $200 | -$18,800.00 | -- | -- |
| 12/31/2018 | Q4 | -- | -- | -$32,000.00 | -- | -- |
| 09/30/2018 | Q3 | -- | -- | -$2,902,400.00 | -- | -- |
| 06/30/2018 | Q2 | -- | -- | -$102,400.00 | -- | -- |
| 03/31/2018 | Q1 | -- | $91.2K | -$44,800.00 | -- | -- |
| 12/31/2017 | Q4 | -- | -- | -$36,800.00 | -- | -- |
| 09/30/2017 | Q3 | -- | -- | -$25,600.00 | -- | -- |
| 06/30/2017 | Q2 | -- | -- | -$91,200.00 | -- | -- |
| 03/31/2017 | Q1 | -- | -- | -$38,400.00 | -- | -- |
| 12/31/2016 | Q4 | -- | -- | -$233,600.00 | -- | -- |
| 09/30/2016 | Q3 | -- | -- | -$436,800.00 | -- | -- |
| 06/30/2016 | Q2 | -- | -- | -$292,800.00 | -- | -- |
| 03/31/2016 | Q1 | -- | -- | -$227,200.00 | -- | -- |
Sunshine Biopharma, Inc. reported $9.4M worth of top line sales in its most recent quarter.
Sunshine Biopharma, Inc. announced earnings per share of -$0.19 which represents a miss of analyst forecast a -- per share.
Sunshine Biopharma, Inc. reported $3M that represents $0.65 per share over the last quarter.
Sunshine Biopharma, Inc.'s earnings are forecast to grow from -$7.32 per share to -- per share next year representing an increase of --.
Currently, Sunshine Biopharma, Inc. has not yet stated when its earnings date is, however, based on past estimates it's likely to take place on April 8, 2026.
Signup to receive the latest stock alerts
In Q3, legendary macro investor Stan Druckenmiller sold his entire…
AI cloud computing business CoreWeave (NASDAQ:CRWV) has been through a…
In Q3, billionaire Stan Druckenmiller bought about 4,620 shares of…
Market Cap: $4.6T
P/E Ratio: 64x
Market Cap: $3.9T
P/E Ratio: 36x
Market Cap: $3.8T
P/E Ratio: 39x
Regencell Bioscience Holdings Ltd. [RGC] is up 22.74% over the past day.
Innodata, Inc. [INOD] is up 4.84% over the past day.
AeroVironment, Inc. [AVAV] is up 6.62% over the past day.